BioSpace News Archive

Pharm Country

icotec ag raises $30m in growth financing from MVM Partners

icotec ag is pleased to announce a significant milestone in its growth journey by establishing a strategic partnership with MVM Partners, a global healthcare venture capital firm.

January 24, 2024
·
3 min read
Awakn Life Sciences Completes Successful Investigative Study to Establish Dissociative Effect of a Proprietary Sublingual S-Ketamine Oral Thin Film Formulation in Harmful Drinkers

Awakn Designates Program AWKN-002 for Alcohol Use Disorders in the US Market

January 24, 2024
·
6 min read
Business

23andMe to Report FY2024 Third Quarter Financial Results

23andMe Holding Co., a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced that it will report financial results for the fiscal year 2024 third quarter after the market closes on Wednesday, February 7, 2024.

January 24, 2024
·
3 min read
Biotech Beach

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced installation and completion of an initial procedure with both the ClearPoint Prism Neuro Laser Therapy System and the ClearPoint Neuro Navigation System by Dr. Jonathan Riley and team at Kaleida Health in Buffalo, New York.

January 24, 2024
·
4 min read
Pharm Country

Tourmaline Bio Announces Proposed Public Offering of Common Stock - Jan 24, 2024

Tourmaline Bio, Inc. announced the launch of a proposed underwritten public offering of its common stock.

January 24, 2024
·
5 min read
Business

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024

ResMed Inc. announced results for its quarter ended December 31, 2023.

January 24, 2024
·
20 min read
BioMidwest

Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 24, 2024

Ocuphire Pharma, Inc. announced that the independent members of its Board of Directors approved equity awards under Ocuphire’s 2021 Inducement Plan, as a material inducement to two new employees in connection with their employment with the Company effective on January 18, 2024.

January 24, 2024
·
4 min read
Pharm Country

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 24, 2024

GeneDx announced that, effective as of January 23, 2024, the compensation committee of GeneDx’s board of directors granted newly hired employees 106,030 restricted stock units as inducements material to each employee entering into employment with GeneDx.

January 24, 2024
·
1 min read
Business

Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors

Charles River Laboratories International, Inc. announced the appointment of Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer, Novartis US, to its Board of Directors.

January 24, 2024
·
5 min read
Business

Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, will report its financial results for the fourth quarter and full year 2023 on Thursday, February 15, 2024, following the close of the market.

January 24, 2024
·
1 min read